FDA — authorised 23 September 1997
- Marketing authorisation holder: HOSPIRA
- Status: approved
🇺🇸 Corlopam in United States
FDA authorised Corlopam on 23 September 1997
Marketing authorisations
FDA — authorised 23 September 1997
- Application: NDA019922
- Marketing authorisation holder: HOSPIRA
- Local brand name: CORLOPAM
- Indication: INJECTABLE — INJECTION
- Status: approved
Corlopam in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Corlopam approved in United States?
Yes. FDA authorised it on 23 September 1997; FDA authorised it on 23 September 1997.
Who is the marketing authorisation holder for Corlopam in United States?
HOSPIRA holds the US marketing authorisation.